Gerday Sara, Schleich Florence, Henket Monique, Guissard Françoise, Paulus Virginie, Louis Renaud
I GIGA Research Group, University of Liege, 4000 Liege, Belgium.
Department of Pulmonary Medicine, CHU Sart-Tilman, 4000 Liege, Belgium.
World Allergy Organ J. 2022 Jun 1;15(6):100655. doi: 10.1016/j.waojou.2022.100655. eCollection 2022 Jun.
Atopic asthma is one of the most common asthma phenotypes and is generally opposed to the non-atopic counterpart. There have been very few large-scale studies comparing atopic and non-atopic asthmatics in terms of systemic and airway inflammation across the age spectrum.
Here, we have undertaken a retrospective study investigating 1626 patients (924 atopic and 702 non-atopic asthmatics) recruited from our university asthma clinic who underwent extensive clinical investigations including induced sputum. Atopy was defined by any positive specific IgE to common aeroallergens (>0,35 kU/L). We performed direct comparisons between the groups and sought to appreciate the influence of age on the airway and systemic inflammatory components. The study was approved by the ethics committee of the University Hospital of Liege (Ref. 2016/276). Informed consents were obtained from healthy subjects.
Atopic asthmatics were younger < .001), had a higher male/female ratio < .001), an earlier disease onset < .001) and a greater proportion of treated rhinitis < .001) while non-atopic asthmatics had greater smoke exposure < .001), lower FEV/FVC ratio ( = .01) and diffusing capacity ( < .001). There was no difference between the 2 groups regarding FEV (% predicted), asthma control, asthma quality of life and exacerbations in the previous 12 months. Regarding inflammation, atopic patients had higher FeNO levels (median = 28 ppb, < .001), were more eosinophilic both in blood (median = 2.8%, < .001) and in sputum (median = 2.2%, < .001) while non-atopic patients displayed greater blood (median = 57%, = .01) and sputum (median = 58.8%, = .01) neutrophilic inflammation. However, stratifying patients by age showed that non-atopic asthmatics above 50 years old became equally eosinophilic in the sputum = .07), but not in the blood, as compared to atopic patients. Likewise, FeNO rose in non-atopic patients after 50 years old but remained, however, lower than in atopic patients.
We conclude that, while sharing many features, atopic group still differentiates from non-atopic asthmatics by demographics, functional and inflammatory profiles. When atopic asthmatics showed a constant eosinophilic pattern across the age spectrum, non-atopic asthmatics were found to be neutrophilic before the age of 50 but eosinophilic above 50 years old.
特应性哮喘是最常见的哮喘表型之一,通常与非特应性哮喘相对。很少有大规模研究在全年龄范围内比较特应性和非特应性哮喘患者的全身和气道炎症情况。
在此,我们进行了一项回顾性研究,调查了从我校哮喘诊所招募的1626例患者(924例特应性哮喘患者和702例非特应性哮喘患者),这些患者接受了包括诱导痰在内的广泛临床检查。特应性由对常见气传变应原的任何阳性特异性IgE(>0.35 kU/L)定义。我们对两组进行了直接比较,并试图了解年龄对气道和全身炎症成分的影响。该研究获得了列日大学医院伦理委员会的批准(参考号:2016/276)。获得了健康受试者的知情同意书。
特应性哮喘患者更年轻(P<0.001),男女比例更高(P<0.001),发病更早(P<0.001),患治疗性鼻炎的比例更高(P<0.001),而非特应性哮喘患者有更多的吸烟暴露(P<0.001),FEV/FVC比值更低(P=0.01)和弥散功能更低(P<0.001)。两组在FEV1(预测值百分比)、哮喘控制、哮喘生活质量和过去12个月内的急性加重方面没有差异。关于炎症,特应性患者的FeNO水平更高(中位数=28 ppb,P<0.001),血液(中位数=2.8%,P<0.001)和痰液(中位数=2.2%,P<0.001)中的嗜酸性粒细胞更多,而非特应性患者的血液(中位数=57%,P=0.01)和痰液(中位数=58.8%,P=0.01)中的中性粒细胞炎症更明显。然而,按年龄对患者进行分层显示,50岁以上的非特应性哮喘患者在痰液中的嗜酸性粒细胞情况与特应性患者相当(P=0.07),但在血液中并非如此。同样,50岁以后非特应性患者的FeNO升高,但仍低于特应性患者。
我们得出结论,虽然特应性组和非特应性哮喘患者有许多共同特征,但在人口统计学、功能和炎症特征方面仍存在差异。当特应性哮喘患者在全年龄范围内呈现持续的嗜酸性粒细胞模式时,非特应性哮喘患者在50岁之前以中性粒细胞为主,50岁以上则以嗜酸性粒细胞为主。